News

A team of UK researchers have homed in on a protein, called RIT1, that may act as a master switch in the brain. A new five-year, $2.5 million grant from the National Institutes of Health will help them explore RIT1 as a possible target for treatments to counteract brain injury.

UK computational chemist Chad Risko starts at the atomic level to design new materials for lithium ion batteries and electrical grid storage.

Greg Copley, UK CAER, serves as an outreach and technical coordinator for the Local Government Energy Retrofit Program, working with local and county government officials to implement performance savings conservation measures at public facilities across the Commonwealth.

It turns out that work done by students in the UK College of Agriculture, Food and Environment could have a big impact on people living in sub-Saharan Africa.

Last week, the UK Office of Technology Commercialization held its second annual Patent Palooza, an event that celebrates the university's inventors and commercialization deals of the previous fiscal year.

The third annual International Society of Neurogastronomy Symposium brought together experts from the worlds of food and neuroscience to explore what we eat and why.

For the second year, the University of Kentucky Office of Technology Commercialization (OTC) will host Patent Palooza, an event that celebrates the university's inventors and commercialization deals for the previous fiscal year.

Dr. Maya Guglin presented data that shows adding beta blockers or ACE inhibitors to a chemotherapy regimen for patients with HER2-positive breast cancer significantly reduces cardiotoxicity.

CTOP is educating and empowering UK undergrads, from Kentucky’s Appalachian counties, through hands-on cancer research, clinical observation and shadowing, classroom and workshop learning, and community outreach in the participants’ own towns and neighborhoods.

With the Markey Cancer Center, Ellingson uses molecular docking as a filtering process to efficiently and safely screen potential drugs before real-world experiments begin.